Oriahnn™ (elagolix/estradiol/norethindrone acetate; elagolix) – New drug approval
May 29, 2020 - FDA announced the approval of AbbVie’s Oriahnn (elagolix/estradiol/norethindrone acetate; elagolix), for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.
Top